Crinetics Pharmaceuticals

Driving the next generation of endocrinology care.
See our social community guidelines:

[Crinetics Pharmaceuticals @Crinetics]

For many patients, advocacy happens in the everyday moments – in the conversations navigated, the symptoms managed, and the questions asked. And in those moments, having the right information, support, and connection can make all the difference. That’s why we’re proud to introduce Everyday Advocacy, our new initiative to empower patients, strengthen education, and elevate the voices of those living with endocrine diseases.

Learn more: https://t.co/swWkyhOfgM

[Crinetics Pharmaceuticals @Crinetics]

We’re looking forward to attending #ENDO2026 and contributing to the ongoing dialogue that’s shaping the future of endocrine care.

We will be presenting data in acromegaly, congenital adrenal hyperplasia, and ACTH-dependent Cushing’s syndrome, underscoring our commitment to advancing understanding in areas of high unmet need. Read more: https://t.co/WZsTHU3KAo

[Crinetics Pharmaceuticals @Crinetics]

This Mental Health Awareness Month, we're proud to invest in the whole person, because at Crinetics, we succeed together, and that starts with taking care of each other. From onsite fitness to a culture rooted in compassion and continuous growth, supporting our team is part of how we power what's possible for patients.

Learn more about life at Crinetics: https://t.co/j1nHMU4qnO

[Crinetics Pharmaceuticals @Crinetics]

Today we announced that our treatment for adults with acromegaly has received approval by the European Commission. This marks another step forward in expanding access to treatment for patients with acromegaly in Europe. Read more: https://t.co/7zlkJVLKXj

#Acromegaly #Endocrinology

[Crinetics Pharmaceuticals @Crinetics]

Hormones play a role in nearly every system in the body, and when they’re out of balance, the effects can show up in unexpected ways. This World Hormone Day, Crinetics’ Bob Cuddihy, SVP of Medical Affairs, highlights the role of the endocrine system and common signs of imbalance. Watch to learn more:

#HormoneAwareness #EndocrineHealth #Biotech

[Crinetics Pharmaceuticals @Crinetics]

At #AACE2026, we’re contributing to the scientific exchange shaping endocrine care. Join us for an oral presentation tomorrow at 9:00am to explore thyroid management considerations in patients with acromegaly.

🗓 April 24, 2026
⏰ 9:00 – 9:15 AM PT
📍 Room 116

#ClinicalResearch #Biotech

[Crinetics Pharmaceuticals @Crinetics]

We’re looking forward to participating at #AACE2026 and contributing to the ongoing dialogue in endocrine care. We’ll be sharing two oral presentations at this year’s event. See below for session details and timing.

[Crinetics Pharmaceuticals @Crinetics]

Our culture is powered by people, and more than a few four-legged coworkers 🐾 From virtual dog walls to dog-friendly offices, we love celebrating what makes our teams feel at home. Meet a few of our four-legged coworkers ⬇️

Learn more about our culture: https://t.co/SnYuCFyLk5

#CompanyCulture #Biotech #Dogs #DogsatWork

[Crinetics Pharmaceuticals @Crinetics]

Crinetics was built on the conviction that patients with underserved endocrine diseases deserve better. Crinetics cofounders Scott Struthers and Stephen Betz recently joined @PituitaryWorldNews to share what drove them to build a different kind of biotech company. Watch the full interview: https://t.co/ARNFLAzi5w

[Crinetics Pharmaceuticals @Crinetics]

Watch Crinetics CEO and cofounder Scott Struthers sit down with leading patient advocate @talkingacromegalywithtony to discuss the everyday reality of living with acromegaly: https://t.co/pBgT50Vi8Y

[Crinetics Pharmaceuticals @Crinetics]

We recently announced the submission of a Marketing Authorization Application for our proposed acromegaly treatment in Brazil.
Read more about this filing and our ongoing work in endocrinology: https://t.co/3eGrJcOW0y

#MAA #Endocrinology

[Crinetics Pharmaceuticals @Crinetics]

For people living with Cushing’s, the path to answers isn’t always straightforward. Symptoms can vary, mental and cognitive effects are often common, and even advanced imaging may not always reveal the cause. This Cushing’s Awareness Day, we’re raising awareness of the challenges patients may face and why continued progress in endocrine care matters.

We’re also proud to acknowledge the work of the Cushing’s Support & Research Foundation (CSRF), whose commitment to patient advocacy, education, and community-building helps ensure that no one navigates this journey alone.

By elevating awareness and supporting patient communities, we can help drive more informed care and more connected experiences for those affected by endocrine diseases.

#CushingsAwarenessDay #Health

[Crinetics Pharmaceuticals @Crinetics]

We’re proud to share that Isabel Kalofonos, Chief Commercial Officer at Crinetics, has been named a 2026 MM+M Pinnacle Awards honoree. This recognition reflects her leadership in advancing a bold vision for the future of endocrine diseases that’s grounded in innovation, global impact, and an unwavering commitment to patients. It also honors her ability to lead with clarity and purpose in moments that demand resilience from our industry. Congratulations, Isabel!

#Leadership #Innovation

[Crinetics Pharmaceuticals @Crinetics]

In celebration of National Science Day, we asked our team what science means to them. 🔬

At Crinetics, the passion and curiosity of our scientists drive the discoveries that aim to improve the lives of people living with endocrine diseases.

Interested in joining our team? We’re hiring:
• VP, Clinical Endocrinology
• VP, Drug Safety/ Pharmacovigilance

[Crinetics Pharmaceuticals @Crinetics]

In honor of the internet’s favorite trend, we asked our office dogs to describe themselves on LinkedIn. Swipe to see what they said ➡️

Think you’re a fit for our pack? We’re hiring:
https://t.co/DKtduGhWwF

[Crinetics Pharmaceuticals @Crinetics]

We’re proud to share that a systematic literature review and network meta-analysis evaluating pharmacologic therapies in acromegaly has been accepted for publication in the Journal of Clinical Endocrinology & Metabolism. This milestone reflects our ongoing commitment to advancing scientific understanding and supporting the endocrine community.

[Crinetics Pharmaceuticals @Crinetics]

This International Women’s Day, we’re recognizing the women who help drive mission, culture, and impact. Today, we’re proud to spotlight Adriana Cabré and her contributions to advancing our work in endocrinology.

#InternationalWomensDay

[Crinetics Pharmaceuticals @Crinetics]

BIO has appointed our CEO, Dr. Scott Struthers, to its Board of Directors. The board plays a key role in shaping policy and supporting scientific innovation across the global biotechnology community. Scott’s experience advancing therapies for endocrine diseases will contribute to those efforts and to BIO’s mission of improving patient outcomes worldwide.

Congratulations to Scott, and thank you to BIO for your continued leadership in strengthening the biotech ecosystem.

[Crinetics Pharmaceuticals @Crinetics]

Ready to help shape the future of endocrinology?

Crinetics is seeking a Vice President, Clinical Endocrinology to play a pivotal role in advancing innovative therapies for patients living with endocrine diseases. If you’re passionate about translating science into meaningful impact for patients, we’d love to connect. Apply today: https://t.co/k8YdnoPpTB

[Crinetics Pharmaceuticals @Crinetics]

Every person with a rare disease has a story. This Rare Disease Day, take a moment to hear from others living with a rare disease like acromegaly: https://t.co/R3pQXiZYOu